ArticleInvestigative ophthalmology & visual science2026
Impact of Myopia Control Spectacles on Retinal Image Contrast.
Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Oculomotor Profiles in Children Wearing Different Myopia Control Lenses: A Real-World Eye Tracking Study.Vision (Basel, Switzerland) · 2026Article
- Short-Term Axial Length Effects of Combining Paracentral Collimating Apertures with Near-Peripheral Myopic Defocus for Myopia Control.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Peripheral defocus and image contrast modulation are key strategies in myopia control, but both inherently reduce retinal image contrast. To date, no in vivo study has directly compared these effects. This study evaluated the contrast reduction profiles of different myopia control spectacles to better understand their underlying mechanisms. Methods: Through-focus images (TFIs) were obtained with a double-pass instrument in a model eye and in human eyes wearing four spectacle designs: DIMS, Stellest, diffusion optics technology (DOT), and MyoCare. The naked eye served as a reference. Thirteen participants (mean age = 29.0 ± 3.5 years) were tested at the fovea and at 10° and 20° eccentricities in the temporal and superior fields. Lenses were decentered by 1.5 cm to assess off-axis effects. Model eye tests included only the central field. Retinal image contrast (RIC) was calculated as the coefficient of variation of pixel intensity in TFIs. Results: In the model eye, RIC ranked from highest to lowest as follows: naked eye, DIMS, DOT, MyoCare, and Stellest. In vivo, DOT results were excluded due to a weak signal. A nonparametric test revealed significant differences in RIC among lenses at the fovea (P = 0.009) and at 10° in the temporal/superior fields (P = 0.05). Post hoc analysis showed that Stellest produced the greatest reduction in RIC, whereas MyoCare and DIMS demonstrated similar levels of contrast loss. Conclusions: All myopia control lenses reduced retinal image contrast, with Stellest inducing the strongest reduction. MyoCare and DIMS showed comparable effects. Lens-induced optics primarily influenced contrast in the near periphery, while ocular optics dominated at larger eccentricities.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.